Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation

被引:8
|
作者
Kreyenberg, H. [1 ]
Eckert, C. [2 ]
Yarkin, Y. [3 ]
Reising, M. [1 ]
Willasch, A. [1 ]
Handgretinger, R. [3 ]
Kremens, B. [4 ]
von Stackelberg, A. [2 ]
Henze, G. [2 ]
Klingebiel, T. [1 ]
Bader, P. [1 ]
机构
[1] Goethe Univ Frankfurt, Dept Paediat Oncol Haematol & Haemostaseol, Childrens Hosp, Frankfurt, Germany
[2] Humboldt Univ, Dept Paediat Oncol Haematol, Charite Hosp, Berlin, Germany
[3] Univ Tubingen, Dept Haematol Oncol, Childrens Univ Hosp, Tubingen, Germany
[4] Univ Essen Gesamthsch, Dept Pediat Haematol Oncol & Endocrinol, Essen, Germany
关键词
CONCERTED ACTION; RELAPSE; PROTOCOLS; CHILDREN; PRIMERS;
D O I
10.1038/leu.2009.72
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1355 / 1358
页数:5
相关论文
共 50 条
  • [11] Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients
    Toubai, T
    Tanaka, J
    Ota, S
    Fukuhara, T
    Hashino, S
    Kondo, T
    Kasai, M
    Kakinoki, Y
    Masauzi, N
    Morioka, M
    Kawamura, T
    Iwasaki, H
    Asaka, M
    Imamura, M
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 80 (03) : 181 - 187
  • [12] Ig/T-Cell Receptor Clonality Testing as a Method for Minimal Residual Disease Monitoring in T-Cell Acute Lymphoblastic Leukemia Patients
    Panovska-Stavridis, Irina
    Ridova, Nevenka
    Ivanovski, Martin
    Trajkova, Sanja
    Pivkova-Veljanovska, Aleksandra
    Chadievski, Lazar
    Dukovski, Dushko
    Stojanoski, Zlate
    Popova-Labachevska, Marija
    Kochoski, Bozidar
    Stojanovska-Jakimovska, Simona
    Cvetanoski, Milche
    Grivchevska, Milena
    Kostojchinoska, Viktorija
    Jakjimovski, Mario
    Hamamdzieva, Ilina
    Dimovski, Aleksandar S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S200 - S201
  • [13] T cell receptor gene rearrangements in childhood acute lymphoblastic leukemia and its implication for detection of minimal residual disease
    Sun, L
    Quah, TC
    Yeoh, AEJ
    Lee, BW
    CANCER RESEARCH THERAPY & CONTROL, 1996, 5 (01): : 59 - 65
  • [14] T-cell receptor γ and δ gene rearrangements in T-cell acute lymphoblastic leukemia in Indian patients
    Kode, J
    Advani, S
    Chiplunkar, S
    LEUKEMIA & LYMPHOMA, 2000, 36 (3-4) : 331 - 338
  • [15] Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia
    Della Starza, Irene
    Nunes, Vittorio
    Cavalli, Marzia
    De Novi, Lucia Anna
    Ilari, Caterina
    Apicella, Valerio
    Vitale, Antonella
    Testi, Anna Maria
    Del Giudice, Ilaria
    Chiaretti, Sabina
    Foa, Robin
    Guarini, Anna
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (04) : 541 - 549
  • [16] NGS of immunoglobulin and T-cell receptor genes repertoire for minimal residual disease diagnostics in pediatric acute lymphoblastic leukemia
    Miroshnichenkova, A.
    Komkov, A.
    Zerkalenkova, E.
    Popov, A.
    Nugmanov, G.
    Mamedov, I.
    Olshanskaya, Y.
    Maschan, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 939 - 940
  • [17] Monitoring of immunoglobulin and T cell receptor genes rearrangements in acute lymphoblastic leukemia.
    Davidjan, Y. R.
    Surin, V. L.
    Parovichnikova, E. N.
    Savchenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2006, 51 (02): : 3 - 10
  • [18] SIMULTANEOUS IMMUNOGLOBULIN T-CELL RECEPTOR GENE REARRANGEMENTS AND MULTICLONALITY IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    FORESTIER, E
    NORDENSON, I
    LINDSTROM, A
    ROOS, G
    LINDH, J
    ACTA PAEDIATRICA, 1994, 83 (03) : 319 - 326
  • [19] T-cell receptor beta gene locus as a target for minimal residual disease detection in acute lymphoblastic leukemia
    Chen, X
    Neale, G
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 86 - 86
  • [20] IS IMMUNOGLOBULIN/T-CELL RECEPTOR MEASURABLE RESIDUAL DISEASE MONITORING TRULY INFORMATIVE IN PH plus ACUTE LYMPHOBLASTIC LEUKEMIA?
    Beldinanzi, M.
    Della Starza, I.
    Bellomarino, V.
    Cardinali, D.
    Elia, L.
    Matarazzo, M.
    Soscia, R.
    Cola, M.
    Di Trani, M.
    Foa, R.
    Chiaretti, S.
    HAEMATOLOGICA, 2024, 109 : 78 - 78